Production of Ergot Alkaloids in the Opava Pharmaceutical Factory
Chemické listy · 15.05.2026 · 120 (5) · 251-257
DOI: 10.54779/chl20260251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemické listy, online erschienen am 15.05.2026. Verfasst von Ladislav Cvak.
Abstract (Originalsprache)
Research and production of ergot alkaloids began in former Czechoslovakia as early as the 1950s. In 1963, the production was transferred to the company Galena Opava, and this small pharmaceutical plant gradually became the world's largest producer of ergot alkaloids, manufacturing the full range of therapeutically used substances, both natural and semisynthetic. It has maintained this position up to the present day, now as part of the company TAPI, headquartered in Israel. The production is based on the extraction of field ergot, and it is precisely the perfected technology of its cultivation that forms the foundation of the company's success in this field.
Zitieren
APA
Cvak, L. (2026). Production of Ergot Alkaloids in the Opava Pharmaceutical Factory. Chemické listy, 120(5), 251-257. https://doi.org/10.54779/chl20260251
Vancouver
Cvak L. Production of Ergot Alkaloids in the Opava Pharmaceutical Factory. Chemické listy. 2026;120(5):251-257. doi:10.54779/chl20260251
BibTeX
@article{Cvak2026,
author = {Cvak, Ladislav},
title = {Production of Ergot Alkaloids in the Opava Pharmaceutical Factory},
journal = {Chemické listy},
year = {2026},
volume = {120},
number = {5},
pages = {251--257},
doi = {10.54779/chl20260251}
}
EUVIMED